Zum Inhalt der Seite gehen

Suche

Beiträge, die mit xec getaggt sind

With the LP.8.1.* variant on the way to dominance in most places, it is time to ponder which variant might drive the next wave.

The leading contenders at this point are LF.7.7.2, LF.7.9, NB.1.8.1, XEC.25.1 and XFH.

I show them here using a log scale, so you can compare their growth rates vs the most common LP.8.1.* sub-lineage: LP.8.1.1.

I show them here using a log scale, so you can compare their growth rates vs the incumbent LP.8.1.1 (19%).

#COVID19 #LF_7_7_2 #LF_7_9 #NB_1_8_1 #XEC #XFH
🧵

#COVID19 #xec #lf_7_7_2 #lf_7_9 #nb_1_8_1 #xfh

Here's the latest variant picture for Europe (excluding the UK), to early March.

The XEC.* variant remains dominant, but it has declined to around 31% frequency.

The LP.8.1.* variant grew to around 23%.

Note the recent sample volumes are very low, so this might not be a representative picture.

#COVID19 #EUR #XEC #LP_8_1
🧵

#COVID19 #EUR #xec #lp_8_1

Here's the latest variant picture for the United States, to mid-March.

The LP.8.1.* variant has continued to grow steadily to around 49%.

The XEC.* variant continued to fall, down to around 19%.

#COVID19 #USA #XEC #LP_8_1
🧵

#COVID19 #usa #xec #lp_8_1

Here's the latest variant picture for Australia, to early March.

XEC.* continues to dominate, although fairly flat at around 50-60%.

The LP.8.1.* variant grew to around 18%, finally challenging the DeFLuQE variants as the new challenger.

#COVID19 #Australia #XEC #LP_8_1 @auscovid19
🧵

#COVID19 #Australia #xec #lp_8_1 @AusCOVID19 group

Here's the latest variant picture with a global scope, to mid- March.

The LP.8.1.* variant grew to around 38%, taking over dominance from the declining XEC.* variant.

#COVID19 #Global #XEC #LP_8_1
🧵

#COVID19 #global #xec #lp_8_1

Here's the latest variant picture for the United Kingdom, to early March.

The XEC.* variant remains dominant, but it has fallen to around 44% frequency.

The LP.8.1.* variant grew somewhat to 21%, but then fell back in recent samples to finish at around 17%.

#COVID19 #UK #XEC #LP_8_1
🧵

#uk #COVID19 #xec #lp_8_1

Here's the latest variant picture for the United Kingdom.

The XEC.* variant remains dominant, but growth has stalled at around 60% frequency.

The LP.8.1.* variant grew somewhat to 19% frequency, but then fell back in recent samples to finish at around 15%.

#COVID19 #UK #XEC #LP_8_1
🧵

#uk #COVID19 #xec #lp_8_1

Here's the latest variant picture for Europe (excluding the UK).

The XEC.* variant is dominant, holding in the range of 60-70%.

The JN.1.* + DeFLuQE and JN.1.* + FLiRT variants are in decline.

#COVID19 #EUR #XEC
🧵

#COVID19 #EUR #xec

Here's the latest variant picture for the United States.

The XEC.* variant has been overtaken by the LP.8.1.* variant - growing steadily to around 34%.

There’s a rebound underway among the JN.1.* + FLiRT variants, led by the LB.1.3.1 lineage.

#COVID19 #USA #XEC #LP_8_1
🧵

#COVID19 #usa #xec #lp_8_1

Here's the latest variant picture for New Zealand.

DeFLuQE variants continue to dominate, with XEC.* struggling to break above 40%.

This quite an unusual picture as XEC.* is already dominant in most places.

The LP.8.1.* variant has mostly been below 10%.

#COVID19 #NZ #DeFLuQE #XEC #LP_8_1
🧵

#COVID19 #nz #defluqe #xec #lp_8_1

Here's the latest variant picture with a global scope.

The XEC.* variant has continued to decline, while the LP.8.1.* variant grew to around 23%.

There seems to be a rebound in the JN.1.* + FLiRT family, rising recently to around 12%

#COVID19 #Global #XEC #LP_8_1
🧵

#COVID19 #global #xec #lp_8_1

Here's the latest variant picture for the United States.

The XEC.* variant is still dominant, but looks like losing top spot shortly.

The LP.8.1.* variant has been growing steadily – up to around 31% and on track to take over from XEC.*.

#COVID19 #USA #XEC #LP_8_1
🧵

#COVID19 #usa #xec #lp_8_1

Here's the latest variant picture for the United Kingdom.

XEC.* remains dominant, but growth has stalled at around 70%.

The LP.8.1.* variants have grown to around 14% frequency.

#COVID19 #UK #XEC #LP_8_1
🧵

#uk #COVID19 #xec #lp_8_1

Here's the latest variant picture for the United Kingdom.

Growth of XEC.* continued, to around 76%.

The new LP.8.1.* variants are present, but have struggled to grow above 10% frequency. Globally, this group looks like the most likely challenger.

#COVID19 #UK #XEC #LP_8_1
🧵

#uk #COVID19 #xec #lp_8_1

Here's the latest variant picture for Europe (excluding the UK).

Growth of XEC.* continued, to around 55%.

The new LP.8.1.* variants are present, didn’t make the cut of the top 6. Globally, this group looks like the most likely challenger.

#COVID19 #EUR #XEC #LP_8_1
🧵

#COVID19 #EUR #xec #lp_8_1

Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but they now appear to be in decline.

Growth of XEC.* has continued, reaching 37% recently.

#COVID19 #Global #DeFLuQE #XEC
🧵

#COVID19 #global #defluqe #xec

With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contenders at this point are LP.8.1 and XEC.4.

I show them here using a log scale, so you can compare their growth rates vs OG XEC.

#COVID19 #XEC #LP_8_1
🧵

#COVID19 #xec #lp_8_1

With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contenders at this point are LP.8.1 and XEC.4.

They are shown here using a log scale, so you can compare their growth rates vs OG XEC.

#COVID19 #XEC #LP_8_1
🧵

#COVID19 #xec #lp_8_1

Here's the latest variant picture for the United States.

DeFLuQE variants are still dominant, but growth has ended.

XEC.* growth might have stalled at around 20%, but recent sample sizes are thin.

#COVID19 #USA #DeFLuQE #FLiRT #XEC
🧵

#COVID19 #usa #defluqe #xec #FLiRT

Here's the latest variant picture for the United Kingdom.

DeFLuQE variants continue to dominate, but they are now in decline.

XEC.* grew to around 40%.

#COVID19 #UK #DeFLuQE #KP_3_1_1 #XEC
🧵

#uk #COVID19 #defluqe #xec #kp_3_1_1

Here's the latest variant picture for Japan.

DeFLuQE variants have been rising to take over dominance from FLuQUE variants.

XEC.* grew to around 14%, but might have stalled there.

The recent rise in FLiRT variants is led by the LP.8.1 variant.

#COVID19 #Japan #DeFLuQE #FLiRT #FLuQE #XEC
🧵

#COVID19 #Japan #defluqe #xec #FLiRT #FLuQE

Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but growth appears to have stalled.

Growth of XEC.* has continued, reaching 28%.

#COVID19 #Global #DeFLuQE #XEC
🧵

#COVID19 #global #defluqe #xec

⇧